Gastrointestinal Stromal Tumors

  • Blueprint Medicines (BPMC) Given “Outperform” Rating at Wedbush – Fairfield Current
    Read More
  • Jan 30, 2019 finreviewer.com
    CASI Pharmaceuticals Inc. (CASI) and Deciphera Pharmaceuticals Inc. (NASDAQ:DCPH) Comparison side by side – The FinReviewer
    Read More
  • Jan 30, 2019 bharatapress.com
    Analysing Xencor (XNCR) & Citius Pharmaceuticals (CTXR) – BharataPress
    Read More
  • Jan 30, 2019 whatsonthorold.com
    Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Shorted Shares Increased By 20.72% | Thorold News – Thorold News
    Read More
  • Zacks: Brokerages Expect Deciphera Pharmaceuticals Inc (DCPH) Will Announce Earnings of -$0.69 Per Share – Fairfield Current
    Read More
  • Jan 30, 2019 dminute.com
    Reviewing Deciphera Pharmaceuticals Inc. (DCPH)’s and NewLink Genetics Corporation (NASDAQ:NLNK)’s results – D Minute
    Read More
  • Jan 30, 2019 finheadlines.com
    Celldex Therapeutics Inc. (CLDX) and PDL BioPharma Inc. (NASDAQ:PDLI) Contrasting side by side – The FinHeadLines
    Read More
  • Jan 30, 2019 dminute.com
    Contrasting of Tonix Pharmaceuticals Holding Corp. (TNXP) and Celldex Therapeutics Inc. (NASDAQ:CLDX) – D Minute
    Read More
  • Jan 30, 2019 finheadlines.com
    Reviewing PLx Pharma Inc. (PLXP)’s and Celldex Therapeutics Inc. (NASDAQ:CLDX)’s results – The FinHeadLines
    Read More

Connect. Empower. Inspire.